Advances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy.

Area of Science:

• Oncology
• Immunology
• Nanotechnology

Background:

• Malignant tumors remain a leading cause of death, with current therapies exhibiting limitations like high mortality and severe side effects.
• Cancer immunotherapy, focused on activating the host's antitumor immune response, is a rapidly advancing field.
• The tumor microenvironment plays a critical role in cancer progression and therapeutic response.

Purpose of the Study:

• To review current knowledge on macrophage classification, polarization mechanisms, and their role in the tumor microenvironment.
• To discuss strategies for reprogramming immunosuppressive M2 macrophages to a proinflammatory M1 phenotype.
• To explore challenges and approaches in targeted delivery of immunostimulatory signals to tumor macrophages using nanoparticles.

Main Methods:

• Literature review of macrophage biology, tumor immunology, and nanoparticle-based drug delivery systems.
• Analysis of mechanisms governing macrophage polarization (M1 vs. M2 phenotypes).
• Examination of strategies for modulating macrophage function within the tumor microenvironment.

Main Results:

• Macrophage polarization is a key factor in shaping the tumor microenvironment, with M2 macrophages often promoting tumor growth and M1 macrophages mediating antitumor immunity.
• Reprogramming M2 macrophages to M1 is a critical goal for effective cancer immunotherapy.
• Nanoparticle-based delivery systems offer potential for targeted delivery of therapeutic agents to tumor-associated macrophages.

Conclusions:

• Modulating macrophage polarization represents a promising strategy for cancer immunotherapy.
• Targeted delivery of immunostimulatory signals using nanoparticles is crucial for overcoming challenges in reprogramming tumor macrophages.
• Further research into nanoparticle-mediated macrophage reprogramming could lead to more effective cancer treatments.